BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31587628)

  • 1. Impaired Action Control in Patients With Functional Movement Disorders.
    van Wouwe NC; Mohanty D; Lingaiah A; Wylie SA; LaFaver K
    J Neuropsychiatry Clin Neurosci; 2020; 32(1):73-78. PubMed ID: 31587628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action Control Deficits in Patients With Essential Tremor.
    Hughes S; Claassen DO; van den Wildenberg WPM; Phibbs FT; Bradley EB; Wylie SA; van Wouwe NC
    J Int Neuropsychol Soc; 2019 Feb; 25(2):156-164. PubMed ID: 30501660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative neurocircuit perspective on psychogenic nonepileptic seizures and functional movement disorders: neural functional unawareness.
    Perez DL; Dworetzky BA; Dickerson BC; Leung L; Cohn R; Baslet G; Silbersweig DA
    Clin EEG Neurosci; 2015 Jan; 46(1):4-15. PubMed ID: 25432161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal Versus External Frame of Reference in Functional Movement Disorders.
    Vizcarra JA; Hacker S; Lopez-Castellanos R; Ryes L; Laub HN; Marsili L; Dwivedi AK; LaFaver K; Espay AJ
    J Neuropsychiatry Clin Neurosci; 2020; 32(1):67-72. PubMed ID: 31564234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in unity: The go/no-go and stop signal tasks rely on different mechanisms.
    Raud L; Westerhausen R; Dooley N; Huster RJ
    Neuroimage; 2020 Apr; 210():116582. PubMed ID: 31987997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonepileptic attack disorder and functional movement disorder: A clinical continuum?
    Rather MA; Cavanna AE
    Epilepsy Behav; 2020 May; 106():107028. PubMed ID: 32203928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural activity in functional movement disorders after inpatient rehabilitation.
    Faul L; Knight LK; Espay AJ; Depue BE; LaFaver K
    Psychiatry Res Neuroimaging; 2020 Sep; 303():111125. PubMed ID: 32585576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A supramodal role of the basal ganglia in memory and motor inhibition: Meta-analytic evidence.
    Guo Y; Schmitz TW; Mur M; Ferreira CS; Anderson MC
    Neuropsychologia; 2018 Jan; 108():117-134. PubMed ID: 29199109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's Disease Subtypes Show Distinct Tradeoffs Between Response Initiation and Inhibition Latencies.
    Tolleson C; Turchan M; van Wouwe N; Isaacs D; Phibbs F; Wylie S
    J Int Neuropsychol Soc; 2017 Sep; 23(8):665-674. PubMed ID: 28850018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep-brain stimulation of the subthalamic nucleus improves overriding motor actions in Parkinson's disease.
    van den Wildenberg WPM; van Wouwe NC; Ridderinkhof KR; Neimat JS; Elias WJ; Bashore TR; Wylie SA
    Behav Brain Res; 2021 Mar; 402():113124. PubMed ID: 33422595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent component analysis of functional networks for response inhibition: Inter-subject variation in stop signal reaction time.
    Zhang S; Tsai SJ; Hu S; Xu J; Chao HH; Calhoun VD; Li CS
    Hum Brain Mapp; 2015 Sep; 36(9):3289-302. PubMed ID: 26089095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of restless legs syndrome in functional movement disorders: a case-control study from the Czech Republic.
    Serranová T; Slovák M; Kemlink D; Šonka K; Hallett M; Růžička E
    BMJ Open; 2019 Jan; 9(1):e024236. PubMed ID: 30670516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor Retraining (MoRe) for Functional Movement Disorders: Outcomes From a 1-Week Multidisciplinary Rehabilitation Program.
    Jacob AE; Kaelin DL; Roach AR; Ziegler CH; LaFaver K
    PM R; 2018 Nov; 10(11):1164-1172. PubMed ID: 29783067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of
    Spagnolo PA; Norato G; Maurer CW; Goldman D; Hodgkinson C; Horovitz S; Hallett M
    J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):814-821. PubMed ID: 32576619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theory of mind: A clue for the interpretation of functional movement disorders.
    Silveri MC; Di Tella S; Lo Monaco MR; Petracca M; Tondinelli A; Antonucci G; Pozzi G; Di Lazzaro G; Calabresi P; Bentivoglio AR
    Acta Neurol Scand; 2022 May; 145(5):571-578. PubMed ID: 35112347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response inhibition in patients with functional neurological symptom disorder.
    Hammond-Tooke GD; Grajeda FT; Macrorie H; Franz EA
    J Clin Neurosci; 2018 Oct; 56():38-43. PubMed ID: 30145086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory Control and Information Processing in ADHD: Comparing the Dual Task and Performance Adjustment Hypotheses.
    Fosco WD; Kofler MJ; Alderson RM; Tarle SJ; Raiker JS; Sarver DE
    J Abnorm Child Psychol; 2019 Jun; 47(6):961-974. PubMed ID: 30547312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired awareness of motor intention in functional neurological disorder: implications for voluntary and functional movement.
    Baek K; Doñamayor N; Morris LS; Strelchuk D; Mitchell S; Mikheenko Y; Yeoh SY; Phillips W; Zandi M; Jenaway A; Walsh C; Voon V
    Psychol Med; 2017 Jul; 47(9):1624-1636. PubMed ID: 28183377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional (psychogenic) movement disorders associated with normal scores in psychological questionnaires: A case control study.
    van der Hoeven RM; Broersma M; Pijnenborg GH; Koops EA; van Laar T; Stone J; van Beilen M
    J Psychosom Res; 2015 Sep; 79(3):190-4. PubMed ID: 26113484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implicit motor imagery using laterality recognition in functional movement disorders.
    Navaratnam D; Harm K; Fenton A; Bullock-Saxton J; Griffin A; Lehn A
    J Clin Neurosci; 2021 Jul; 89():139-143. PubMed ID: 34119257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.